✦ LIBER ✦

A phase II trial of dose-intensive interleukin-2 in metastatic renal cell carcinoma

✍ Scribed by Leslie Oleksowicz; Janice P. Dutcher

Publisher: Springer-Verlag
Year: 1999
Tongue: English
Weight: 123 KB
Volume: 125
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s004320050249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential administration of interferon

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

✍ Manuela Schmidinger; Günther G. Steger; Catharina Wenzel; Gottfried J. Locker; T 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

A phase II trial of palliative radiother

A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma

✍ Justin Lee; David Hodgson; Edward Chow; Andrea Bezjak; Pamela Catton; Debbie Tsu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

A phase-II study of low-dose cyclophosph

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma

✍ Albrecht Lindemann; Klaus Höffken; Reinhold E. Schmidt; Volker Diehl; Otto Kloke 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 937 KB

Granulocyte-macrophage-colony stimulatin

Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma : A phase II trial

✍ Brian I. Rini; Walter M. Stadler; Ricardo T. Spielberger; Mark J. Ratain; Nichol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## BACKGROUND. Due to lack of success with standard chemotherapy and only modest

A Phase I trial of fixed dose rate gemci

A Phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma

✍ Brian I. Rini; Vivian Weinberg; Eric J. Small 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## BACKGROUND Metastatic renal cell carcinoma (RCC) has modest response rates to chemotherapy with gemcitabine and 5‐fluorouracil (5‐FU). Fixed dose rate gemcitabine infusion leads to enhanced intracellular accumulation of drug and possible augmented clinical effect. To determine the t

A Phase II trial of bryostatin-1 for pat

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma

✍ Lance Pagliaro; Danai Daliani; Robert Amato; Shi-Ming Tu; Donnah Jones; Terry Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views